ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,037.88
      0.72%
      US Tech 100
      20,916.80
      0.93%
      Dow Jones
      44,556.04
      0.30%
      Brent Oil
      75.765
      -0.23%
      Bitcoin
      97,585.07
      -0.28%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Italy
      5. BIT

      6. Sanofi (1SAN) Quote

      Sanofi

      Sanofi (1SAN)

      BIT
      102.56
      -2.16
      (-2.06%)
      Closed February 04 11:30AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      102.56
      Bid
      102.00
      Ask
      103.20
      Volume
      3,183
      102.54 Day's Range 104.38
      84.98 52 Week Range 107.96
      Market Cap
      128.471B
      Previous Close
      104.72
      Open
      104.38
      Last Trade
      219
      @
      102.56
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      863
      Shares Outstanding
      1,252,640,466
      Dividend Yield
      3.67%
      PE Ratio
      23.82
      Earnings Per Share (EPS)
      4.31
      Revenue
      43.07B
      Net Profit
      5.4B

      About Sanofi

      Sector
      Health & Allied Services,nec
      Industry
      Pharmaceutical Preparations
      Website
      www.sanofi.com
      Headquarters
      Paris, Paris, Fra
      Founded
      1994
      Sanofi is listed in the Health & Allied Services sector of the Italian Stock Exchange with ticker 1SAN. The last closing price for Sanofi was 104.72 €. Over the last year, Sanofi shares have traded in a share price range of 84.98 € to 107.96 €.

      Sanofi currently has 1,252,640,466 shares outstanding. The market capitalization of Sanofi is 131.18 € billion. Sanofi has a price to earnings ratio (PE ratio) of 23.82.

      Ask ADVFN Intelligence (AI)

      1SAN Latest News

      More News

      Communiqué de presse : Sanofi annonce un rachat d'actions à L'Oréal

      Communiqué de presse : Sanofi annonce un rachat d'actions à L'Oréal Sanofi annonce un rachat d'actions à L'Oréal Paris, le 3 février 2025. Sanofi annonce aujourd'hui l'acquisition de...

      February 03 2025
      UK Regulatory

      Press Release: Sanofi announces buy back of shares from L’Oréal

      Press Release: Sanofi announces buy back of shares from L’Oréal Sanofi announces buy back of shares from L’Oréal Paris, February 3, 2025. Sanofi today announces the acquisition of 2.3% of its...

      February 03 2025
      UK Regulatory

      Press Release: Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant

      Press Release: Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant Sarclisa is the first anti-CD38 treatment...

      January 31 2025
      UK Regulatory

      Communiqué de presse : Sarclisa est le premier anti-CD38 approuvé en Chine pour le traitement du myélome multiple nouvellement diagnostiqué des patients non éligibles à une greffe

      Communiqué de presse : Sarclisa est le premier anti-CD38 approuvé en Chine pour le traitement du myélome multiple nouvellement diagnostiqué des patients non éligibles à une greffe Sarclisa est le...

      January 31 2025
      UK Regulatory

      Press Release: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025

      Press Release: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025 Sanofi: Q4 sales growth of 10.3%, 2024 business EPS guidance...

      January 30 2025
      UK Regulatory

      Communiqué de presse : Croissance des ventes de 10,3% au T4. Objectif du BNPA des activités de 2024 dépassé. Fort rebond du BNPA des activités attendu en 2025

      Communiqué de presse : Croissance des ventes de 10,3% au T4. Objectif du BNPA des activités de 2024 dépassé. Fort rebond du BNPA des activités attendu en 2025 Sanofi: Croissance des ventes de...

      January 30 2025
      UK Regulatory

      Sanofi: Informations relatives au nombre de droits de vote et d'actions - Decembre 2024

      Sanofi: Informations relatives au nombre de droits de vote et d'actions - Decembre 2024 Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II...

      January 29 2025
      UK Regulatory

      Sanofi: Information concerning the total number of voting rights and shares - December 2024

      Sanofi: Information concerning the total number of voting rights and shares - December 2024 Information concerning the total number of voting rights and shares, provided pursuant to article L...

      January 29 2025
      UK Regulatory

      Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma

      Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma Sarclisa approved...

      January 22 2025
      UK Regulatory

      Communiqué de presse : Approbation du Sarclisa dans l’UE – premier anti-CD38 en association avec le schéma VRd de référence pour le traitement du myélome multiple nouvellement diagnostiqué de l’adulte non éligible à une greffe

      Communiqué de presse : Approbation du Sarclisa dans l’UE – premier anti-CD38 en association avec le schéma VRd de référence pour le traitement du myélome multiple nouvellement diagnostiqué de...

      January 22 2025
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      12.262.25324027916100.3104.6100.3994102.94842826DE
      47.918.3571051241494.65104.693.170499.82693464DE
      127.778.1970672011894.79104.687.4886394.06330759DE
      266.436.6888588369996.13107.9687.4878597.35267923DE
      5214.8616.944127708187.7107.9684.9884993.62960022DE
      15610.211.043741879692.36107.9676.3692291.90272662DE
      26014.3516.267996825888.21107.9668145987.87547145DE

      1SAN - Frequently Asked Questions (FAQ)

      What is the current Sanofi share price?
      The current share price of Sanofi is 102.56 €
      How many Sanofi shares are in issue?
      Sanofi has 1,252,640,466 shares in issue
      What is the market cap of Sanofi?
      The market capitalisation of Sanofi is EUR 131.18B
      What is the 1 year trading range for Sanofi share price?
      Sanofi has traded in the range of 84.98 € to 107.96 € during the past year
      What is the PE ratio of Sanofi?
      The price to earnings ratio of Sanofi is 23.82
      What is the cash to sales ratio of Sanofi?
      The cash to sales ratio of Sanofi is 2.99
      What is the reporting currency for Sanofi?
      Sanofi reports financial results in EUR
      What is the latest annual turnover for Sanofi?
      The latest annual turnover of Sanofi is EUR 43.07B
      What is the latest annual profit for Sanofi?
      The latest annual profit of Sanofi is EUR 5.4B
      What is the registered address of Sanofi?
      The registered address for Sanofi is 46, AVENUE DE LA GRANDE ARMEE, PARIS, PARIS, 75017
      What is the Sanofi website address?
      The website address for Sanofi is www.sanofi.com
      Which industry sector does Sanofi operate in?
      Sanofi operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WAMB26Ambromobiliare SpA
      0.0599 €
      (81.52%)
      		17.88k
      EPHEPH SpA
      0.041 €
      (30.16%)
      		629.97k
      1PLTRPalantir Technologies Inc
      101.76 €
      (27.26%)
      		137.15k
      WELESEles Spa
      0.137 €
      (25.69%)
      		100
      WRDF25Redelfi SpA
      1.5082 €
      (20.66%)
      		30
      WGIS26Gismondi 1754 SpA
      0.053 €
      (-49.52%)
      		15.2k
      WSMN26Simone SpA
      0.0493 €
      (-29.47%)
      		13k
      WABTGAlfio Bardolla Training Group Spa
      0.0997 €
      (-21.50%)
      		66.25k
      1ELXEstee Lauder Companies
      65.60 €
      (-17.59%)
      		1.34k
      WPOZ27Pozzi Milano Spa
      0.079 €
      (-16.67%)
      		19.05k
      TITTelecom Italia SpA
      0.2722 €
      (1.08%)
      		44.17M
      TITRTelecom Italia
      0.3168 €
      (2.19%)
      		36.29M
      ISPIntesa Sanpaolo Spa
      4.2545 €
      (1.99%)
      		36.17M
      ENELEnel Spa
      6.899 €
      (0.19%)
      		10.35M
      FDAFidia
      0.015 €
      (11.94%)
      		8.77M

      Discussion

      View Full Feed
      RobotDroid RobotDroid 3 minutes ago
      Hahaha another dreamer of Hopium surfaces. What a hoot!
      NWBO
      hockeypond hockeypond 3 minutes ago
      I agree....seeing more volume. I couldn't resist .025 then I'm hoping for the run we had up to .52 in October 2023
      ECGS
      havnagoodtime havnagoodtime 4 minutes ago
      ...been ages since I've read this board. WTF?!?! >> zero volume last Friday but 447mil volume yesterday??? Conventional wisdom tells us that MAJOR frontloading took place. If that's the case, that means Kate actually has a legit deal (no head fake) and she dished out insider info to a select group.
      QEDN
      236T568 236T568 4 minutes ago
      Yikes!

      https://bsky.app/profile/davidsirota.com/post/3lhf6myf2dc2p
      carlson carlson 5 minutes ago
      I want to THANK all who make this board what it is. You all know who you are.
      NBRI
      arizona1 arizona1 5 minutes ago
      The only thing DEI does is to get your resume into the pile without any knowledge of who or what you are. If you get past the first round, apparently you're qualified enough to get an interview. You actually haven't the foggiest clue how real life hiring goes.
      in99flyers in99flyers 6 minutes ago
      1,499,235 holders of Shiba. On the brink of passing 1.5 million holders. Great accomplishment for the community. Big things coming
      SHIBUSD
      NASDAQ2020 NASDAQ2020 7 minutes ago
      That’s just a coincidence. A lot of people buy 911 shares at a time.


      ELTP
      ELTP
      JJ8 JJ8 7 minutes ago
      Order to buy shares AH at $190 filled. GLTA
      GOOG
      ExtremelyBullishZig ExtremelyBullishZig 8 minutes ago
      Tomorrow's earnings meeting held the support...look out after the meeting.
      AVXL
      12yearplan 12yearplan 8 minutes ago
      Yes, only been two weeks, let's give them some time shall we 🙂
      a surfer a surfer 9 minutes ago
      I already have 799,000 shares. But tried to add today for the heck of it.
      YCRM
      ChannelTrader ChannelTrader 9 minutes ago
      Thought you'd like to see this very short video.

      https://www.youtube.com/shorts/6QygHdTlthI
      IceCold8 IceCold8 9 minutes ago
      Thanks,getmoreshares! With that many involved this isn't going anywhere! Very sobering and I just drank some whiskey!
      CGAC
      TheRealMrPirate TheRealMrPirate 9 minutes ago
      shareholders can also contact him to investigate what's the hold up and why shareholders are being lied to by lawyers
      Ya, about that. There are no longer shareholders here
      Didn't you get the memo ? - https://ised-isde.canada.ca/cc/lgcy/fdrlCrpSrch.html?locale=en_CA
      Make sure you
      ExtremelyBullishZig ExtremelyBullishZig 10 minutes ago
      There already is another gap at $5.85. see you down there.
      AVXL
      rich2 rich2 10 minutes ago
      now I am educated, thank you

      this is really getting interesting WOW


      in 2025 NBRI will FLY. Most of us can see gold In that picture

      Got gold, do some greal good DD and decided for yourself
      NBRI
      olivernoyes olivernoyes 11 minutes ago
      DeFi Technologies Signs Binding LOI with CoreFi Strategy and Orinswift Ventures, Secures US$20M CORE Token Commitment from the Core Foundation to Drive Bitcoin Finance
      PR NEWSWIRE

      Feb-04-2025 7:30 a.m. ET

      Strategic Collaboration and Reverse Takeover: DeFi Technol
      AMZN CBSTF DEFTF
      12yearplan 12yearplan 11 minutes ago
      You know Lime. There was a time when Lime enjoyed no time.
      There was scurvy, there was lemons and oranges etc,..
      Then, there was emancipation becuz
      Limes have been around for thousands of years, but their popularity has fluctuated over time
      Historically, limes were first
      TreasuredTrades TreasuredTrades 12 minutes ago
      Steve Carnes is notorious for running gutter trash OTC scams. Samson, you are right on. The most recent favorite of mine involving that scam artist was the TLIF Rock Climbing Park.

      I agree with you 100%. Steve Carnes is likely the mastermind here. Over $13M stripped from the market ca
      INKW
      Golden Cross Golden Cross 12 minutes ago
      Form 4 Buy
      https://ih.advfn.com/stock-market/NASDAQ/golden-matrix-GMGI/stock-news/95370093/form-4-statement-of-changes-in-beneficial-owners
      GMGI
      Stock Guy777 Stock Guy777 12 minutes ago
      Probably stop everyone out and then they'll let it rip
      AMD
      Stock Guy777 Stock Guy777 13 minutes ago
      I'm sure you were immediately stopped out. Lol
      AMD

      Your Recent History

      BIT
      1SAN
      Sanofi
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads